/BVXP.L
BVXP.L Stock - Bioventix PLC
Healthcare|BiotechnologyLSE
$1810.00+1.97%
+$35.00 (+1.97%) • Dec 22
54
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.3
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1991.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BVXP.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1791.90 – $1828.10
TARGET (TP)$2081.50
STOP LOSS$1665.20
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.63
52W High$3490.00
52W Low$1650.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $13.12M | $13.61M | $12.82M | $11.72M | $10.93M |
| Gross Profit | $11.92M | $12.68M | $11.86M | $10.87M | $9.98M |
| Gross Margin | 90.9% | 93.2% | 92.5% | 92.7% | 91.3% |
| Operating Income | $9.90M | $10.60M | $10.04M | $9.27M | $8.09M |
| Net Income | $7.58M | $8.10M | $8.37M | $7.67M | $6.73M |
| Net Margin | 57.8% | 59.5% | 65.3% | 65.5% | 61.6% |
| EPS | $1.45 | $1.55 | $1.61 | $1.47 | $1.29 |
Company Overview
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BVXP.LBeat Rate
0%
Last 2 quarters
Avg Surprise
-5.4%
EPS vs Estimate
Beats / Misses
0/2
Last 12 quarters
Latest EPS
$0.72
Q4 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q1 23
-3.3%
$0.71vs$0.73
Q4 23
No data
Q1 24
No data
Q4 24
No data
Q1 25
No data
Q4 25
-7.6%
$0.72vs$0.78
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | — | — | — | — |
Q4 2025 | Oct 27, 2025 | $0.78 | $0.72 | -7.6% | ✗ MISS |
Q1 2025 | Mar 31, 2025 | — | $0.71 | — | — |
Q4 2024 | Oct 28, 2024 | — | $0.78 | — | — |
Q1 2024 | Mar 25, 2024 | — | $0.76 | — | — |
Q4 2023 | Oct 30, 2023 | — | $0.87 | — | — |
Q1 2023 | Mar 27, 2023 | $0.73 | $0.71 | -3.3% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | — | $0.89 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.57 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.69 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.59 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.70 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.68 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.60 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.53 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.54 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.54 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.56 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.39 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.41 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BVXP.L
What is BVXP.L's current stock price?
Bioventix PLC (BVXP.L) is currently trading at $1810.00 per share. The stock has moved +1.97% today.
What is the analyst price target for BVXP.L?
No analyst price targets are currently available for this stock.
What sector is Bioventix PLC in?
Bioventix PLC operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the LSE exchange.
What is BVXP.L's market cap?
Bioventix PLC has a market capitalization of $0.09 billion, making it a small-cap company.
Does BVXP.L pay dividends?
No, Bioventix PLC does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector4BB.L
4basebio PLC
$615.00
Mkt Cap: $9.5B
AREC.L
Arecor Therapeutics plc
$80.50
Mkt Cap: $3.0B
DXRX.L
Diaceutics PLC
$128.00
Mkt Cap: $10.8B
EKF.L
EKF Diagnostics Holdings plc
$25.30
Mkt Cap: $11.4B
HEMO.L
Hemogenyx Pharmaceuticals Plc
$634.00
Mkt Cap: $3.8B
HVO.L
hVIVO plc
$6.50
Mkt Cap: $4.5B
IMM.L
ImmuPharma plc
$5.30
Mkt Cap: $2.7B
OBI.L
Ondine Biomedical Inc.
$9.00
Mkt Cap: $3.9B
SBTX.L
SkinBioTherapeutics Plc
$13.25
Mkt Cap: $3.4B
SCLP.L
Scancell Holdings plc
$9.90
Mkt Cap: $10.3B
Explore stocks similar to BVXP.L for comparison